Synthesis of oxygenated oleanolic and ursolic acid derivatives with anti-inflammatory properties

Article abstract of DOI:10.1016/j.bmcl.2015.07.029

The scalable syntheses of four oxygenated triterpenes have been implemented to access substantial quantities of maslinic acid, 3-epi-maslinic acid, corosolic acid, and 3-epi-corosolic acid. Semi-syntheses proceed starting from the natural products oleanolic acid and ursolic acid. Proceeding over five steps, each of the four compounds can be synthesized on the gram scale. Divergent diastereoselective reductions of α-hydroxy ketones provided access to the four targeted diol containing compounds from two precursors of the oleanane or ursane lineage. These compounds were subsequently evaluated for their ability to inhibit inflammatory gene expression in a mouse model of chemically induced skin inflammation. All compounds possessed the ability to inhibit the expression of one or more inflammatory genes induced by 12-O-tetradecanoylphorbol-13 acetate in mouse skin, however, three of the compounds, corosolic acid, 3-epi-corosolic acid and maslinic acid were more effective than the others. The availability of gram quantities will allow further testing of these compounds for potential anti-inflammatory activities as well as cancer chemopreventive activity.

Full text of DOI:10.1016/j.bmcl.2015.07.029

Accepted Manuscript
Synthesis of Oxygenated Oleanolic and Ursolic Acid Derivatives with Anti-
inflammatory Properties
Andrew T Nelson, Andrew M. Camelio, Karin R. Claussen, Jiyoon Cho, Lisa
Tremmel, John DiGiovanni, Dionicio Siegel
PII:
S0960-894X(15)00733-7
DOI:
http://dx.doi.org/10.1016/j.bmcl.2015.07.029
BMCL 22918
Reference:
Bioorganic & Medicinal Chemistry Letters
To appear in:
Received Date:
Revised Date:
Accepted Date:
29 June 2015
10 July 2015
13 July 2015
Please cite this article as: Nelson, A.T., Camelio, A.M., Claussen, K.R., Cho, J., Tremmel, L., DiGiovanni, J., Siegel,
D., Synthesis of Oxygenated Oleanolic and Ursolic Acid Derivatives with Anti-inflammatory Properties, Bioorganic
& Medicinal Chemistry Letters (2015), doi: http://dx.doi.org/10.1016/j.bmcl.2015.07.029
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Synthesis of Oxygenated Oleanolic and Ursolic Acid Derivatives with Anti-inflammatory Properties
Andrew T Nelson,1,2 Andrew M. Camelio,1 Karin R. Claussen,1 Jiyoon Cho3, Lisa Tremmel3, John DiGiovanni3, Dionicio
Siegel1,2
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego.
2Department of Chemistry, University of Texas at Austin, Department of Pharmacology and Toxicology, College of
Pharmacy, The University of Texas at Austin
Abstract
The scalable syntheses of four oxygenated triterpenes have been implemented to access substantial quantities of
maslinic acid, 3-epi-maslinic acid, corosolic acid, and 3-epi-corosolic acid. Semi-syntheses proceed starting from the
natural products oleanolic acid and ursolic acid. Proceeding over five steps, each of the four compounds can be
synthesized ongram scale. Divergent diastereoselective reductions of α-hydroxy ketones provided access to the four
targeted diol containing compounds from two precursors of the oleanane or ursane lineage. These compounds were
subsequently evaluated for their ability to inhibit inflammatory gene expression in a mouse model of chemically induced
skin inflammation. All compounds possessed the ability to inhibit the expression of one or more inflammatory genes
induced by 12-O-tetradecanoylphorbol-13 acetate in mouse skin, however, three of the compounds, corosolic acid, 3-epi-
corosolic acid and maslinic acid were more effective than the others. The availability of gram quantities will allow further
testing of these compounds for potential anti-inflammatory activities as well as cancer chemopreventive activity.
Introduction
Cancer continues to be a burden on mankind with 14.1 million new cases and 8.2 million cancer deaths in 2012.1
These figures are projected to increase to 22.2 million new cases and 13.2 million deaths by the year 2030.2 If melanoma
and non-melanoma skin cancers (squamous cell carcinoma, basal cell carcinoma, etc.) are all placed under the umbrella
of skin cancer, then this malignancy is the most common in the world,3 particularly among fair populations.4 According to
the World Health Organization, skin cancer accounts for one third of all cancer diagnoses.5 Furthermore, the incidence of
skin cancer is on the rise.4 Estimates indicate that from 1975-2006 there were more cases of skin cancer in the United

States than all other cancers combined.6 Thus, there is tremendous need to develop new agents for prevention and/or
treatment of skin and other cancers 28, 29
.
Figure 1. Structures of oleanane and ursane carbocyclic cores and oleanolic acid, and ursolic acid.
In light of previous studies showing the anti-tumor promoting activity of ursolic acid 4 (Figure 1) in a murine two-
stage skin carcinogenesis experiment 30-32, the same mouse model was used to explore the efficacy of four pentacyclic
triterpene natural products with ursolic acid-like structure and oxidative pattern: maslinic acid 5, 3-epi-maslinic acid 6,
corosolic acid 7, and 3-epi-corosolic acid 8 (Figure 2). Maslinic acid and 3-epi-maslinic acid are oleanane triterpenes,
while corosolic acid and 3-epi-corosolic acid are of the ursane variety. Oleanane 1 triterpenes differ from ursane 2
triterpenes in the position of a methyl group at C20 in lieu of C19. All four have been isolated from plant sources,
including Perilla frutescens,7, 8 whose leaves are a common ingredient in Chinese, Japanese, and Korean cuisine.9
Figure 2. Structures of maslinic, 3-epi-maslinic, corosolic, and 3-epi-corosolic acids.
P. frutescens also finds use in traditional Chinese medicine as a treatment for gastrointestinal disturbances, fish
and crab poisoning, cough, asthma, and the common cold.10 In more modern work, all four of the abovementioned
triterpenes have shown important biological activity, notably against human cancer cells. Maslinic acid inhibited the
growth of adenoid,11 astrocytoma,12 breast,13, 14 cervical,12 colon,15, 16 fibrosarcoma,17 lung,15 ovarian,15 and melanoma13, 15
cancer cells. The compound 3-epi-maslinic acid demonstrated activity against gastric and uterine cancer cells.18

Corosolic acid slowed the growth of breast,19-21 cervical,22 colon,15, 23 gastric,18, 22 liver,21, 22 leukemia,22, 24 lung,15, 19
melanoma,25 nerve,15 ovarian,19 and uterine18 cancer in vitro. The diastereomer of corosolic acid, 3-epi-corosolic acid,
demonstrated cytotoxic activity against leukemia and breast cancer cell lines.26 While these natural products have shown
anti-cancer activity across many cell types, exploration of their effect on skin cancers like squamous cell carcinoma and
basal cell carcinoma has been limited. Furthermore, there has been a shortage of studies employing these compounds in
whole-organism, in vivo cancer trials as there are challenges in accessing the required quantities of natural product.
Figure 3. Syntheses of maslinic acid and 3-epi-maslinic acid proceeding from oleanolic acid.
In order to evaluate the activity of maslinic acid, 3-epi-maslinic acid, corosolic acid, and 3-epi-corosolic acid in a
murine model of skin cancer, each natural product was synthesized based on literature precedent on gram scale.27
Maslinic acid and 3-epi-maslinic acid were synthesized starting from commercially available oleanolic acid 3 (Figure 3).
The carboxylic acid of oleanolic acid was protected with benzyl chloride in the presence of catalytic potassium iodide to
afford the benzyl ester 9. The crude ester was precipitated by combining the reaction mixture with cold water (0 °C) and,
after filtration, used in the subsequent step without further purification. The secondary alcohol of 9 was oxidized cleanly
with Jones reagent to the corresponding ketone 10. Purification by recrystallization from 200 proof ethanol gave pure 10
as a solid in 81% yield over two steps. Treatment of ketone 10 with m-chloroperbenzoic acid and catalytic sulfuric acid
generated hydroxyketone 11 by diastereoselective oxidation of the transient enol on the less hindered α-face. Reduction
of α-hydroxyketone 11 under different conditions afforded a variable mixture of two diastereomeric vicinal diols 12 and 13.
Sodium borohydride favored formation of diol 12 with hydride delivery to the Si face of the ketone. This selectivity was

reversed under Meerwein-Ponndorf-Verley conditions, favoring diol 13. Deprotection by cleavage of the benzyl ester of
12 was effected using an atmosphere of hydrogen gas and palladium on carbon, generating maslinic acid 5. Subjecting
diol 13 to the same conditions yielded 3-epi-maslinic acid 6.
Corosolic acid 7 and 3-epi-corosolic acid 8 were synthesized in an analogous manner, starting from ursolic acid 4
(Figure 4). The carboxylic acid of ursolic acid was protected as a benzyl ester using benzyl chloride in the presence of
catalytic potassium iodide generating benzyl ester 14. The crude ester was precipitated from the reaction by combining
the reaction mixture with cold water (0 °C) following filtration the crude material was used without further purification. The
secondary alcohol of 14 was oxidized to the ketone through the use of with Dess-Martin periodinane to the yield ketone
15. Purification of ketone 15 by recrystallization from 200 proof ethanol gave pure 15 in 92% yield over two steps.
Treatment of 15 with m-chloroperbenzoic acid and catalytic sulfuric acid generated hydroxyketone 16 by
diastereoselective oxidation of the enol from the less hindered face. Selective reduction of the α-hydroxyketone 16 under
two conditions afforded a different ratio of the vicinal diols, 17 and 18. While sodium borohydride was selective for the
formation of 17 with hydride delivery to the Si face of the ketone the selectivity was reversed using Meerwein-Ponndorf-
Verley conditions to favor diol 18. Reductive deprotection of diol 17 was achieved with hydrogen gas (1 atm) and
palladium on carbon, generating corosolic acid 7. In a similar transformation the diol 18 was debenzylated to yield 3-epi-
corosolic acid 8.
Me
Me
Me
Me
Me
Me
OH
OBn
OBn
BnCl, KI, K2CO3
DMF, 55 °C
DMP, NaHCO3
CH2Cl2, 0 °C
O
92%, 2-steps
mCPBA, H2SO4
MeOH:CH2Cl2, 0 °C
64%
Me Me
H
Me Me
H
Me Me
H
O
O
O
H
Me
H
Me
H
Me
HO
HO
H
H
H
Me Me
Me Me
Me Me
3
14
15
ursolic acid
Me
Me
Me
Me
OH
H
OBn
H
H2, Pd/C
THF, 23 °C
98%
Me Me
Me
Me Me
Me
HO
HO
O
O
H
H
Me
HO
HO
H
H
Me
reagents = NaBH4, THF, 0 °C
17 18
Me Me
7 corosolic acid
Me Me
:
4:1
17
67%
OBn
Me Me
H
HO
O
+
reagents = Al(i-PrO)3, i-PrOH,
reflux, 17:18 1:10
56%
O
H
Me
Me
Me
H
Me Me
Me
Me
16
OBn
H
OH
H2, Pd/C
THF, 23 °C
98%
Me Me
Me
Me Me
H
HO
HO
HO
HO
O
O
H
H
Me
H
H
Me Me
Me Me
8 3-epi-corosolic acid
18
Figure 4. Synthesis of corosolic acid and 3-epi-corosolic acid proceeding from ursolic acid.

Figure 5. Effect of triterpenes found in P. frutescens in TPA-induced inflammatory gene expression in mouse skin
Quantitative mRNA expression (assessed by qRT-PCR) of IL-1α, IL-1β, IL-6, and IL-23 was normalized to GADPH and to the value in
acetone treated mice which was set to a value of 1. The graphs represent means SEM. For statistical analysis, the Mann-Whitney U
test was used. *, significantly greater (p ≤ 0.05) than acetone-treated group; **, significantly lower (p ≤ 0.05) than TPA-treated group; #,
significantly lower (p ≤ 0.05) than UA + TPA group; and ‡, significantly greater (p ≤ 0.05) than UA + TPA group. T; TPA, UA; ursolic
acid, OA; oleanolic acid, CA; corosolic acid, 3-epi-CA; 3-epi-corosolic acid, MA; maslinic acid, and 3-epi-MA; 3-epi-maslinic acid.
In preliminary experiments, the compounds were subsequently tested for their ability to inhibit inflammatory gene
expression induced by topical treatment with the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA) in mouse
skin. Inflammation and changes in inflammatory gene expression are closely linked to the process of skin tumor
promotion by TPA 33-34. For these experiments, six- week old ICR mice (obtained from Harlan Laboratories Inc. Fredrick,
MD) were group housed and maintained on a chow diet for one week. All experiments were carried out according to
institutional and the NIH guidelines. The dorsal skin of mice (at 7 weeks of age) was shaved, and two days later mice
received topical treatments of acetone vehicle (200 µl) or 2 µmol of ursolic acid, oleanolic acid, corosolic acid, 3-epi-
corosolic acid, maslinic acid, or 3-epi-maslinic acid 30 min before 6.8 nmol TPA treatment. All treatments were given
twice-weekly over a two-week period. Epidermal tissue was then harvested 6 hrs after the last TPA treatment for RNA
extraction as previously described 35, 36. For the analysis of inflammatory gene expression, cDNA was prepared from
epidermal RNA samples using High Capacity cDNA Reverse Transcription Kits (AB Applied Biosystems). Briefly, mixtures
were prepared in a total 20 µl volume including 1 µg of RNA, 2 µl 10X RT buffer, 2 µl 10X random primers, 0.8 µl 25X

dNTP mix (100 mM), 1 µl reverse transcriptase and nuclease-free water. The mixtures were run under thermal cycler
condition (25°C for 10 min ꢀ 37°C for 120 min ꢀ 85°C for 5 min ꢀ 4°C for 5 min). For qRT-PCR analysis, 150 ng of
cDNA was mixed with 5 µl of 2X iTagTM universal SYBRR green supermix (Bio-rad), 0.5 µl of 10 μM forward primers, 0.5 μl
○
of 10 μM reverse primers, and nuclease-free water. The mixtures were then subjected to qRT-PCR using ViiATM 7 real time
instrument and analysis software. The Mann-Whitney U test was used to evaluate significant decreases of TPA-induced
gene expression by individual compounds when compared to TPA only treated group.
As shown in Figure 5, all of the compounds had some ability to inhibit TPA-induced mRNA expression of
inflammatory cytokines in the epidermis following topical application. However, corosolic acid, 3-epi-corosolic acid and
maslinic acid were the most effective at inhibition of inflammatory gene expression induced by TPA. In this regard, all
three of these compounds inhibited expression of IL-1α, IL-1β, IL-6 and IL-23 whereas the other compounds, including UA
were less effective overall and in some cases did not significantly inhibit expression of specific genes. Thus, within this
class of related compounds, corosolic acid, 3-epi-corosolic acid and maslinic acid, may be more effective anti-
inflammatory agents. Because of our interest in cancer prevention, these compounds are now being tested in several
mouse models of cancer including the two-stage skin carcinogenesis model for potential anti-carcinogenic activity.
Acknowledgements
Research was supported by NIH/NCI grant CA164159 (to J.D. and D.S.)
References
1. Ferlay, J.; Soerjomataram, I.; Ervik, M.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D. M.; Bray, F.
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency
for Research on Cancer 2013.
2. Bray, F.; Jemal, A.; Grey, N.; Ferlay, J.; Forman, D. Global cancer transitions according to the Human
Development Index (2008–2030): a population-based study. The Lancet Oncology 2012, 13, 790-801.
3. Marneros, A. G.; Bickers, D. R. In Nonmelanoma Skin Cancer; Krieg, Thomas; Bickers, David; Miyachi, Yoshiki,
Ed.; Therapy of Skin Diseases: A Worldwide Perspective on Therapeutic Approaches and Their Molecular Basis;
Springer Science & Business Media: Berlin Heidelberg, 2010; pp 599.
4. Lomas, A.; Leonardi-Bee, J.; Bath-Hextall, F. A systematic review of worldwide incidence of nonmelanoma skin
cancer. British Journal of Dermatology 2012, 166, 1069–1080.
5. WHO Skin Cancers. http://www.who.int/uv/faq/skincancer/en/index1.html.
6. Stern, R. Prevalence of a History of Skin Cancer in 2007: Results of an Incidence-Based Model. Archives of
Dermatology 2010, 146, 279-282.
7. Banno, N.; Akihisa, T.; Tokuda, H.; Yasukawa, K.; Higashihara. H; Ukiya, M.; Watanabe, K.; Kimura, Y.;
Hasegawa, J.; Nishino, H. Triterpene Acids from the Leaves of Perilla frutescens and Their Anti-inflammatory and
Antitumor-promoting Effects. Bioscience, Biotechnology and Biochemistry 2014, 68, 85-90.

8. Woo, K. W.; Han, J. Y.; Choi, S. U.; Kim, K. H.; Lee, K. R. Triterpenes from Perilla frutescens var. acuta and Their
Cytotoxic Activity. Natural Product Sciences 2014, 20, 75.
9. Nitta, M.; Lee, J.; Ohnishi, O. Asian Perilla crops and their weedy forms: Their cultivation, utilization and genetic
relationships. Economic Botany 2003, 57, 253.
10. Chen, Y. In Applications and Prescriptions of Perilla in Traditional Chinese Medicine; Yu, H., Kosuna, K. and
Haga, m., Eds.; Perilla: The Genus Perilla; Taylor & Francis: 1997; pp 37.
11. Wu, D.; Zhao, D.; Li, D.; Xu, D.; Chu, W.; Wang, X. Maslinic acid induces apoptosis in salivary gland adenoid
cystic carcinoma cells by Ca2+-evoked p38 signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology
2011, 383, 321-330.
12. Martin, R.; Carvalho-Tavares, J.; Ibeas, E.; Hernandez, M.; Ruiz-Gutierrez, V.; Nieto, M.L. Acidic Triterpenes
Compromise Growth and Survival of Astrocytoma Cell Lines by Regulating Reactive Oxygen Species Accumulation.
Cancer Research 2007, 67, 3741-3751.
13. Wang, D.; Xia, M.; Cui, Z. New Triterpenoids Isolated from the Root Bark of Ulmus pumila L. Chemical &
Pharmaceutical Bulletin 2006, 54, 775-778.
14Allouche, Y.; Warleta, F.; Campos, M.; Sanchez-Quesada, C.; Uceda, M.; Beltran, G.; Gaforio, J.J. Antioxidant,
Antiproliferative, and Pro-apoptotic Capacities of Pentacyclic Triterpenes Found in the Skin of Olives on MCF-7
Human Breast Cancer Cells and Their Effects on DNA Damage. Journal of Agricultural and Food Chemistry 2011,
59, 121-130.
15. Kim, Y.K.; Yoon, S.K.; Ryu, S.Y. Cytotoxic Triterpenes from Stem Bark of Physocarpus intermedius. Planta
Medica 2000, 66, 485-486.
16. Reyes, F. J.; Centelles, J. J.; Lupiáñez, J. A.; Cascante, M. (2α,3β)-2,3-Dihydroxyolean-12-en-28-oic acid, a new
natural triterpene from Olea europea, induces caspase dependent apoptosis selectively in colon adenocarcinoma
cells. FEBS Letters 2006, 580, 6310.
17. Putz, M.V.; Lazea, M.; Sandjo, L.P. Quantitative Structure Inter-Activity Relationship (QSInAR). Cytotoxicity
Study of Some Hemisynthetic and Isolated Natural Steroids and Precursors on Human Fibrosarcoma Cells HT1080.
Molecules 2011, 16, 6603-6620.
18. Yoshida, M.; Fuchigami, M.; Nagao, T.; Odabe, H.; Matsunaga, K.; Takata, J.; Karube, Y.; Tsuchihashi, R.; Kinjo,
J.; Mihashi, K.; Fujioka, T.Antiproliferative Constituents from Umbelliferae Plants VII. Active Triterpenes and
Rosmarinic Acid from Centella asiatica. Biological & Pharmaceutical Bulletin 2005, 28, 173-175.
19. Khiev, P.; Kwon, O.K.; Song, H.H.; Oh, S.R.; Ahn, K.S.; Lee, H.K.; Chin, Y.W. Cytotoxic Terpenes from the
Stems of Dipterocarpus obtusifolius Collected in Cambodia. Chemical & Pharmaceutical Bulletin 2012, 60, 955-961.
20. Yoon, H.; Liu, R.H. Effect of 2α-Hydroxyursolic Acid on NF-κB Activation Induced by TNF-α in Human Breast
Cancer MCF-7 Cells. Journal of Agricultural and Food Chemistry 2008, 56, 8412-8417.
21. He, X.; Liu, R.H. Triterpenoids Isolated from Apple Peels Have Potent Antiproliferative Activity and May Be
Partially Responsible for Apple's Anticancer Activity. Journal of Agricultural and Food Chemistry 2007, 55, 4366-
4370.
22. Ma, C.; Cai, S.; Cui, J.; Wang, R.; Tu, P.; Hattori, M.; Daneshtalab, M. The cytotoxic activity of ursolic acid
derivatives. European Journal of Medicinal Chemistry 2005, 40, 582-589.
23. Yamagishi, T.; Zhang, D.; Chang, J.; McPhail, D. R.; McPhail, A. T.; Lee, K. The cytotoxic principles of Hyptis
capitata and the structures of the new triterpenes hyptatic acid-A and -B. Phytochemistry 1988, 27, 3213-3216.
24. Cheng; Zhang; Cheng; Chiou; Lee; Kuo Cytotoxic Hexacyclic Triterpene Acids from Euscaphis japonica. Journal
of Natural Products 2010, 73, 1655-1658.

25. Zhao, M.; Bai, L.; Toki, A.; Hasegawa, R.; Sakai, J.; Hasegawa, T.; Ogura, H.; Kataoka, T.; Bai, Y.; Ando, M.;
Hirose, K.; Ando, M. The Structure of a New Cardenolide Diglycoside and the Biological Activities of Eleven
Cardenolide Diglycosides from Nerium oleander. Chemical & Pharmaceutical Bulletin 2011, 59, 371-377.
26. Zheng, C.; Pu, J.; Zhang, H.; Han, T.; Rahman, K.; Qin, L. Sesquiterpenoids and norterpenoids from Vitex
negundo. Fitoterapia 2012, 83, 54.
27. Wen, X.; Sun, H.; Liu, J.; Cheng, K.; Zhang, P.; Zhang, L.; Hao, J.; Zhang, L.; Ni, P.; Zographos, S. E.; Leonidas,
D. D.; Alexacou, K.; Gimisis, T.; Hayes, J. M.; Oikonomakos, N. G. Naturally Occurring Pentacyclic Triterpenes as
Inhibitors of Glycogen Phosphorylase: Synthesis, Structure−Activity Relationships, and X-ray Crystallographic
Studies. Journal of Medicinal Chemistry 2008, 51, 3540-3554.
28. Amin A.R.; Kucuk, O.; Khuri, F.R.; Shin, D.M. Perspectives for cancer prevention with natural compounds.
Journal of Clinical Oncology 2009,27,2712-2725.
29. Chinembiri, T.N.; du Plessis, L.H.; Gerber, M.; Hamman, J.H.; du Plessis, J. Review of natural compounds for
potential skin cancer treatment. Molecules. 2014,19,11679-11721.
30. Huang, M.T.; Ho, C.T.; Wang, Z.Y.; Ferraro, T.; Lou, Y.R.; Stauber, K.; Ma, W.; Georgiadis, C.; Laskin, J.D.;
Conney, A.H. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer
research 1994, 54, 701-708.
31. Kowalczyk, M.C.; Junco, J.J.; Kowalczyk, P.; Tolstykh, O.; Hanausek, M.; Slaga, T.J; Walaszek, Z. Effects of
combined phytochemicals on skin tumorigenesis in SENCAR mice. International Journal of Oncology 2013, 43, 911-
918.
32. Tokuda, H.; Ohigashi, H.; Koshimizu, K.; Ito, Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor
promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Letters. 1986, 33, 279-285.
33. Rundhaug, J.E.; Fischer, S.M. Molecular mechanisms of mouse skin tumor promotion. Cancers 2010, 2, 436-
482.
8. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer science.
2006;97:439-47.
34. Fujiki, H.; Sueoka, E.; Suganuma, M. Tumor promoters: from chemicals to inflammatory proteins. Journal of
Cancer Research and Clinical Oncology. 2013, 139, 1603-1614.
35.Bozeman, R.; Abel, EL.; Macias, E.; Cheng, T.; Beltran, L.; Digiovanni, J. A novel mechanism of skin tumor
promotion involving interferon-gamma (IFNgamma)/signal transducer and activator of transcription-1 (Stat1)
signaling. Molecular carcinogenesis 2014.
36. Rao, D.; Macias, E.; Carbajal, S.; Kiguchi, K.; DiGiovanni, J. Constitutive Stat3 activation alters behavior of hair
follicle stem and progenitor cell populations. Molecular carcinogenesis 2015, 54, 121-133.

Abstract Image
Me
Me
Me Me
inflammatory
gene
Me
Me
expression
OH
OH
OH
Me Me
H
O
Me Me
H
Me Me
H
HO
HO
HO
HO
HO
HO
O
O
H
Me
H
Me
H
Me
H
H
H
Me Me
Me Me
Me Me
maslinic acid
corosolic acid
3-epi-corosolic acid